Andreas S. Beutler

Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials-II: systemic and local non-embolization-based therapies in unresectable and advanced hepatocellular carcinoma.

Carbamazepine is an inhibitor of histone deacetylases.

Intrathecal gene transfer by adeno-associated virus for pain.

Intrathecal long-term gene expression by self-complementary adeno-associated virus type 1 suitable for chronic pain studies in rats.

KLF6 degradation after apoptotic DNA damage.

Sensory neuron targeting by self-complementary AAV8 via lumbar puncture for chronic pain.

The ZNF217 oncogene is a candidate organizer of repressive histone modifiers.

AAV provides an alternative for gene therapy of the peripheral sensory nervous system.

mRNA-seq with agnostic splice site discovery for nervous system transcriptomics tested in chronic pain.

Diametrically opposite methylome-transcriptome relationships in high- and low-CpG promoter genes in postmitotic neural rat tissue.

SAAP-RRBS: streamlined analysis and annotation pipeline for reduced representation bisulfite sequencing.

SERE: single-parameter quality control and sample comparison for RNA-Seq.

Pig lumbar spine anatomy and imaging-guided lateral lumbar puncture: a new large animal model for intrathecal drug delivery.

The genomic landscape of small intestine neuroendocrine tumors.

Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.

Advances in small bowel neuroendocrine neoplasia.

Intraneural convection enhanced delivery of AAVrh20 for targeting primary sensory neurons.

Minimally invasive convection-enhanced delivery of biologics into dorsal root ganglia: validation in the pig model and prospective modeling in humans. Technical note.

Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy.

Preclinical toxicity evaluation of AAV for pain: evidence from human AAV studies and from the pharmacology of analgesic drugs.

RWDD3 and TECTA variants not linked to paclitaxel induced peripheral neuropathy in North American trial Alliance N08C1.

Plasticity of DNA methylation in a nerve injury model of pain.

Exome-level comparison of primary well-differentiated neuroendocrine tumors and their cell lines.

Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance).

Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance).

Calcium and Magnesium Use for Oxaliplatin-Induced Neuropathy: A Case Study to Assess How Quickly Evidence Translates Into Practice.

National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons.

Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance).

Targeted alignment and end repair elimination increase alignment and methylation measure accuracy for reduced representation bisulfite sequencing data.

Neurotoxicity to DRG neurons varies between rodent strains treated with cisplatin and bortezomib.

Future Directions in Pain Management: Integrating Anatomically Selective Delivery Techniques With Novel Molecularly Selective Agents.

Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505).

A pilot study of minocycline for the prevention of paclitaxel-associated neuropathy: ACCRU study RU221408I.

Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical trials.

Oxaliplatin-Induced Peripheral Neuropathy and Identification of Unique Severity Groups in Colorectal Cancer.

Fatal Meningitis in Swine after Intrathecal Administration of Adeno-associated Virus Expressing Syngeneic Interleukin-10.